搜尋結果
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Scanning New Horizons for Bold Solutions
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / October 26, 2022 / Baker Hughes Meet the team working to bring ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved ...
ACCESSWIRE· 2 年前Teva Pharmaceuticals, the National Association of Free and Charitable Clinics (NAFC) and Direct ...
Why Clinical Trial Diversity Is So Important - and What the Healthcare Sector Can Do
ACCESSWIRE· 2 年前Physicians prescribe medication and design treatment and therapy plans for their patients based ...
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of ...
ACCESSWIRE· 2 年前The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University ...
RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Rarebase Is on the Hunt for Therapeutic Opportunities
ACCESSWIRE· 2 年前San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at ...
6G Cybersecurity Will Transform How We Deal With Cyberattacks
ACCESSWIRE· 2 年前As researchers and the industry move towards 6G technology, cybersecurity has been recognized ...